Syncor International

Syncor International was a leading provider of radiopharmaceuticals and nuclear pharmacy services, specializing in the compounding and distribution of radioactive drugs used in diagnostic imaging and therapy. The company operated a vast network of nuclear pharmacies across the United States and internationally, providing unit-dose radiopharmaceuticals for PET and SPECT scans. Their core business supported hospitals and clinics by managing the complex logistics and regulatory requirements associated with handling radioactive materials. In 2003, Syncor was acquired by Cardinal Health in a deal valued at approximately $850 million. This acquisition significantly expanded Cardinal Health's presence in the specialized nuclear medicine market, forming the foundation of its Nuclear Pharmacy Services division.